Is CABA or CANF more undervalued in 2026?

CirclFi compares Cabaletta Bio, Inc. (CABA) and Can-Fite Biopharma Ltd (CANF) using 13 institutional-grade valuation models. CABA has a Quality of Company score of 4.4/10 while CANF scores 2.2/10.

Which is a better buy — CABA or CANF?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CABA and CANF valuations compare?

CABA at $3.77 and CANF at $3.36 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CABA vs CANF Valuation Comparison 2026 — Intrinsic Value Analysis

CABA

Biotechnology

Cabaletta Bio, Inc.

Quality

4.4

out of 10

Value Trap

SAFE

Price

$3.77

Last close

Models

7/13

Active

CANF

Biotechnology

Can-Fite Biopharma Ltd

Quality

2.2

out of 10

Value Trap

SAFE

Price

$3.36

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	CABA Fair Value	CABA Upside	CANF Fair Value	CANF Upside
Bayesian DCF	Intrinsic	$1.10	-70.8%	$0.89	-73.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.45	-61.4%	$2.14	-36.2%
PWERM	Option-Based	$3.83	+1.5%	$2.83	-15.6%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CABA vs CANF — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CABA vs CANF — Which Stock Is More Undervalued?

CABA scores higher with a 4.4/10 quality rating vs CANF's 2.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Cabaletta Bio, Inc. (CABA) and Can-Fite Biopharma Ltd (CANF) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CABA currently trades at $3.77 with a QOC of 4.4/10, while CANF trades at $3.36 with a QOC of 2.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).